New Small-Scale Expression Packages: RushMab™- Ready in just 8 days! LEARN MORE

Biointron Insights: Antibody Industry Report (Q1 2024 Insights, Trends & Analysis) LEARN MORE

Biointron - リコンビナント抗体発現/開発サービス

Antibody Antibody Antibody


Why you should choose us

  • 先進的抗体ソリューション


  • ユニークな細胞株を商品化


  • グローバルな協力体制


  • 信頼と所有権




About Biointron

Biointronは2012年に設立され、ISO 9001:2015認証を取得し、抗体の発見、開発、最適化分野のハイテク企業です。


詳しくはこちら 詳しくはこちら



"We evaluated the 6 proteins you produced for us and we were quite pleased by the results. our internal assessments of the molecules are very encouraging so we would like to potentially expand this further."

— AstraZeneca

"We have tested both batches of the antibodies you sent us. They're active and give comparable results with little batch to batch variation."

— AbbVie

"Excellent.The protein quality and activity was high and up to our standards, we appreciate the help and the work.The short timeline for the production is the main factor Biointron differs from other CROs."

— Moderna

"Great working with you, I've been highly impressed and recommending you to many in my network."

— Sanofi

"I just wanted to give you a quick heads-up regarding the expression we conducted at Biointron. Essentially, everything went well and was super fast, so we are all very much satisfied."

— Merck KGaA

"BioIntron was the best from the three: it was the only company that was able to express all the sequences and the yield for those proteins that the other two companies also could express was, generally, higher."

— ImmuVia, LLC


The start of 2024 has seen leaps in deals for antibody therapeutics, especially ADCs (antibody-drug conjugates). This report aims to explore the events and trends of the biopharmaceutical industry in Q1. As of now, only two novel antibody drugs have been approved this year, but many more in regulatory review are expected to be fully approved.

Apr 07, 2024

Welcome back to Antibody Basics by Biointron, Part 6. In this episode, we’ll talk about Antibody-Drug Conjugates (ADCs), the drug type taking the biopharmaceutical industry by storm.What are antibody-drug conjugates (ADCs)?Composed of a monoclonal antibody (mAb) covalently bonded to a biologically

Apr 19, 2024

​The AACR Annual Meeting 2024 was held in San Diego, CA from April 5-10, and featured the latest advancements in cancer research, with hundreds of poster presentations, lectures, and exhibits. Scientists, health care professionals, and industry experts from around the world gathered to share innovations and trends in oncology, including: Advances in Diagnostics and Therapeutics...

Apr 17, 2024

In March 2024, Cyagen and Biointron officially signed off on their strategic partnership, forging an alliance in antibody drug development. This partnership aims to fully leverage the strengths of Cyagen's HUGO-Ab™ fully humanized mouse antibody discovery platform and Biointron&#

Mar 23, 2024

Biointron is proud to announce a strategic partnership with FatiAbGen, a leading biotechnology firm focused on antibody-based therapeutics. As the newly appointed Korean distributor for Biointron, FatiAbGen will be at the forefront of delivering Biointron’s products to the Korean market.

Mar 15, 2024

Celebrate International Women's Day with Biointron's female workforce!

Mar 15, 2024

Join Biointron at a fun sticker collection game during AACR 2024! Keep an eye on our social media! During this game period, Biointron will continue our daily social postings with Dr.Youngs hidden here and there! Take a screenshot every time you spot one, collect 25+ and win AirPods!

Mar 28, 2024

The Biointron team is excited to announce our participation in the Festival of Biologics 2024.

Dec 14, 2023

Biointron is thrilled to be part of the 4th Fc-Mediated Function Summit, a pivotal event focusing on the latest developments in FcRn, FcγR, and IgG, aiming to enhance related therapeutic applications. This unique conference, happening in Boston from April 16-18, 2024, will be gathering over 80 specialists in the field to share insights on molecular engineering and clinical outcomes.

Mar 20, 2024

お客様の利便性を向上させるためにクッキーを使用しています。詳しくは プライバシーポリシー をご覧ください。